Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients

  • Authors:
    • Elisenda Vendrell
    • Maria Ribas
    • Joan Valls
    • Xavier Solé
    • Mònica Grau
    • Victor Moreno
    • Gabriel Capellà
    • Miguel A. Peinado
  • View Affiliations

  • Published online on: May 1, 2007     https://doi.org/10.3892/ijo.30.5.1099
  • Pages: 1099-1107
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The advent of various ‘omic’ technologies has increased expectations in the field of biomarkers. In an attempt to clarify how different strategies may contribute to improving prognostic classification and to identify new predictors of patient outcome we analyzed genomic and transcriptomic profiles in a series of R0 Dukes B and C colorectal carcinomas. We have compared the predictive capability of each approach against conventional clinicopathological and molecular parameters. At a genomic level, gains at 11q including amplification at 11q13 were an indicator of poorer outcome. In transcriptomic analyses we identified 68 genes whose expression levels correlated with survival (p<0.01) and included overexpression of WASF1, NFE2L2, and MMP9, and underexpression of ITGAL, TSC2, and SDF2. Gene expression levels paralleled chromosomal changes only in 56% of the genes, suggesting that, as a general trend, the direct effect of chromosomal copy number changes on gene expression levels is minimal. Classification of tumors by genomic and transcriptomic signatures resulted in non-overlapping subgroups and was not of prognostic value. We conclude that genomic and transcriptomic profiling of colorectal carcinomas may contribute as novel prognostic markers, but it does not improve outcome prediction when global profiles or signatures are considered.

Related Articles

Journal Cover

May 2007
Volume 30 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Vendrell E, Ribas M, Valls J, Solé X, Grau M, Moreno V, Capellà G and Peinado MA: Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients. Int J Oncol 30: 1099-1107, 2007
APA
Vendrell, E., Ribas, M., Valls, J., Solé, X., Grau, M., Moreno, V. ... Peinado, M.A. (2007). Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients. International Journal of Oncology, 30, 1099-1107. https://doi.org/10.3892/ijo.30.5.1099
MLA
Vendrell, E., Ribas, M., Valls, J., Solé, X., Grau, M., Moreno, V., Capellà, G., Peinado, M. A."Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients". International Journal of Oncology 30.5 (2007): 1099-1107.
Chicago
Vendrell, E., Ribas, M., Valls, J., Solé, X., Grau, M., Moreno, V., Capellà, G., Peinado, M. A."Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients". International Journal of Oncology 30, no. 5 (2007): 1099-1107. https://doi.org/10.3892/ijo.30.5.1099